Bock F, Regenfuss B, Cursiefen C (2011)
Publication Type: Journal article
Publication year: 2011
Book Volume: 108
Pages Range: 230-6
Journal Issue: 3
DOI: 10.1007/s00347-010-2262-0
There are numerous indications for local antiangiogenic therapy at the ocular surface. These include vision-limiting corneal neovascularization, corneal blood and lymphatic vessels endangering corneal graft survival and tumor-associated lymphangiogenesis. A literature review in PubMed and own clinical and experimental data form the basis for a discussion of the indications, current therapeutic options and potential side-effects of local antiangiogenic therapy at the ocular surface.
APA:
Bock, F., Regenfuss, B., & Cursiefen, C. (2011). Antiangiogenic therapy at the ocular surface: when, what and why? Ophthalmologe, 108(3), 230-6. https://doi.org/10.1007/s00347-010-2262-0
MLA:
Bock, F., B. Regenfuss, and Claus Cursiefen. "Antiangiogenic therapy at the ocular surface: when, what and why?" Ophthalmologe 108.3 (2011): 230-6.
BibTeX: Download